Comparing Corteva (NYSE:CTVA) and Cibus (NASDAQ:CBUS)

Corteva (NYSE:CTVA) and Cibus (NASDAQ:CBUS) are both consumer staples companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, valuation, profitability, analyst recommendations, risk, dividends and earnings.

Insider and Institutional Ownership

81.5% of Corteva shares are owned by institutional investors. Comparatively, 33.8% of Cibus shares are owned by institutional investors. 0.2% of Corteva shares are owned by insiders. Comparatively, 49.4% of Cibus shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of current ratings for Corteva and Cibus, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Corteva	0	4	14	1	2.84
Cibus	1	0	2	0	2.33

Corteva presently has a consensus price target of $80.81, indicating a potential upside of 29.01%. Cibus has a consensus price target of $21.25, indicating a potential upside of 1,345.58%. Given Cibus’ higher possible upside, analysts plainly believe Cibus is more favorable than Corteva.

Profitability

This table compares Corteva and Cibus’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Corteva	8.16%	8.68%	5.20%
Cibus	-5,681.55%	-83.67%	-20.85%

Volatility & Risk

Corteva has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500. Comparatively, Cibus has a beta of 1.72, indicating that its stock price is 72% more volatile than the S&P 500.

Valuation and Earnings

This table compares Corteva and Cibus”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Corteva	$16.91 billion	2.52	$907.00 million	$2.05	30.56
Cibus	$4.26 million	18.72	-$251.39 million	($10.45)	-0.14

Corteva has higher revenue and earnings than Cibus. Cibus is trading at a lower price-to-earnings ratio than Corteva, indicating that it is currently the more affordable of the two stocks.

Summary

Corteva beats Cibus on 11 of the 15 factors compared between the two stocks.

About Corteva

Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.

About Cibus

Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.